Favipiravir Market

Favipiravir, also known as T-705, Avigan, or favilavir is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA viruses. Like certain other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative.

In February 2020, fapilavir was used as an experimental treatment for a new coronavirus in China.

Favipiravir Market contains market size and forecasts of Favipiravir in global, including the following market information:

• Global Favipiravir Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Favipiravir Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Favipiravir companies in 2021 (%)

• The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
• Original Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
• The global key manufacturers of Favipiravir include Fujifilm Toyama Chemical, CSPC Pharmaceutical Group, Reyoung Pharmaceutical, Sihuan Pharmaceutical and Hisun Pharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
• We surveyed the Favipiravir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Global Favipiravir Market Segment Percentages, by Type, 2021 (%)

• Original Drug
• Generic Drug

Global Favipiravir Market Segment Percentages, by Application, 2021 (%)

• Influenza Viruses
• HIV
• SARS
• Ebola
• Other

Global Favipiravir Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

The report also provides analysis of leading market participants including:

• Key companies Favipiravir revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Favipiravir revenues share in global market, 2021 (%)
• Key companies Favipiravir sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Favipiravir sales share in global market, 2021 (%)

• Fujifilm Toyama Chemical
• CSPC Pharmaceutical Group
• Reyoung Pharmaceutical
• Sihuan Pharmaceutical
• Hisun Pharm